| TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma P Yang, QJ Li, Y Feng, Y Zhang, GJ Markowitz, S Ning, Y Deng, J Zhao, ... Cancer cell 22 (3), 291-303, 2012 | 574 | 2012 |
| Epithelial-to-mesenchymal transition activates PERK–eIF2α and sensitizes cells to endoplasmic reticulum stress Y Feng, ES Sokol, CA Del Vecchio, S Sanduja, JHL Claessen, TA Proia, ... Cancer discovery 4 (6), 702-715, 2014 | 298 | 2014 |
| Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model YX Feng, T Wang, YZ Deng, P Yang, JJ Li, DX Guan, F Yao, YQ Zhu, ... Hepatology 53 (2), 483-492, 2011 | 130 | 2011 |
| Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1 YX Feng, DX Jin, ES Sokol, F Reinhardt, DH Miller, PB Gupta Nature communications 8 (1), 1-10, 2017 | 122 | 2017 |
| EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex G Li, XD Ji, H Gao, JS Zhao, JF Xu, ZJ Sun, YZ Deng, S Shi, YX Feng, ... Nature communications 3 (1), 1-10, 2012 | 120 | 2012 |
| EphB3 is overexpressed in non–small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration XD Ji, G Li, YX Feng, JS Zhao, JJ Li, ZJ Sun, S Shi, YZ Deng, JF Xu, ... Cancer research 71 (3), 1156-1166, 2011 | 117 | 2011 |
| De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling CA Del Vecchio, Y Feng, ES Sokol, EJ Tillman, S Sanduja, F Reinhardt, ... PLoS biology 12 (9), 2014 | 109 | 2014 |
| RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway S Shi, YZ Deng, JS Zhao, XD Ji, J Shi, YX Feng, G Li, JJ Li, D Zhu, ... Journal of Biological Chemistry 287 (11), 7845-7858, 2012 | 106 | 2012 |
| Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells M Feng, JQ Jin, L Xia, T Xiao, S Mei, X Wang, X Huang, J Chen, M Liu, ... Science Advances 5 (5), eaau5240, 2019 | 91 | 2019 |
| Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer ES Sokol, YX Feng, DX Jin, A Basudan, AV Lee, JM Atkinson, J Chen, ... Annals of Oncology 30 (1), 115-123, 2019 | 82 | 2019 |
| Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis JJ Li, HK Yin, DX Guan, JS Zhao, YX Feng, YZ Deng, X Wang, N Li, ... British journal of cancer 118 (10), 1337-1348, 2018 | 68 | 2018 |
| Dual role for inositol‐requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet‐induced obesity in mice Y Wu, B Shan, J Dai, Z Xia, J Cai, T Chen, S Lv, Y Feng, L Zheng, Y Wang, ... Hepatology 68 (2), 533-546, 2018 | 64 | 2018 |
| Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma T Wang, HS Hu, YX Feng, J Shi, N Li, WX Guo, J Xue, D Xie, SR Liu, ... British journal of cancer 102 (11), 1618-1626, 2010 | 64 | 2010 |
| Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF‐κB signaling pathway YX Feng, JS Zhao, JJ Li, T Wang, SQ Cheng, Y Yuan, F Wang, XF Wang, ... Hepatology 51 (2), 535-544, 2010 | 61 | 2010 |
| TGF-β inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors X Gao, HY Lee, EL Da Rocha, C Zhang, YF Lu, D Li, Y Feng, J Ezike, ... Blood, The Journal of the American Society of Hematology 128 (23), 2637-2641, 2016 | 58 | 2016 |
| AMPK promotes tolerance to Ras pathway inhibition by activating autophagy S Sanduja, Y Feng, RA Mathis, ES Sokol, F Reinhardt, R Halaban, ... Oncogene 35 (40), 5295-5303, 2016 | 56 | 2016 |
| Identification of a selective small molecule inhibitor of breast cancer stem cells AR Germain, LC Carmody, B Morgan, C Fernandez, E Forbeck, TA Lewis, ... Bioorganic & medicinal chemistry letters 22 (10), 3571-3574, 2012 | 44 | 2012 |
| SMARCE1 is required for the invasive progression of in situ cancers ES Sokol, YX Feng, DX Jin, MD Tizabi, DH Miller, MA Cohen, S Sanduja, ... Proceedings of the National Academy of Sciences 114 (16), 4153-4158, 2017 | 42 | 2017 |
| Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers Y Xu, Z Wei, M Feng, D Zhu, S Mei, Z Wu, Q Feng, W Chang, M Ji, C Liu, ... Cell Reports 40 (9), 111295, 2022 | 37 | 2022 |
| Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal T Wang, L Xia, S Ma, X Qi, Q Li, Y Xia, X Tang, D Cui, Z Wang, J Chi, P Li, ... Scientific reports 6 (1), 1-9, 2016 | 27 | 2016 |
Xie Dongchinese academy of sciene在 sibs.ac.cn 的电子邮件经过验证
